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 HMGB proteins are eukaryotic, chromatin-associated proteins that play roles in 
both DNA dynamics and transcription regulation. Hmo1p is an HMGB protein in 
Saccharomyces cerevisiae that behaves somewhat like a hybrid between mammalian 
HMGB proteins and the metazoan linker histone H1. mTORC1, a protein complex 
containing the Tor1p kinase and a major regulator of cellular growth, is inhibited by both 
rapamycin and stress. It has also been shown to not only associate with Hmo1p at various 
gene promoters, but also regulate the HMO1 gene itself through direct binding. In this 
study, the Hmo1p-mTORC1 relationship was further investigated through two questions: 
1) Does the transcription factor Sfp1p play a role in relaying mTORC1’s signal to the 
HMO1 promoter, and 2) Is the reduction in HMO1 transcripts during stress dependent on 
mTORC1? Gene expression analyses revealed that Sfp1p is not required for normal 
HMO1 transcription; however, it does appear to play a role in transmitting the mTORC1 
stress signal to the promoter, as transcripts are only significantly decreased during stress 
when Sfp1p is present. Survival tests revealed that Sfp1p might be hindering the cell’s 
ability to repair DNA double-strand breaks, as there is a slight increase in cell survival 
during double-strand break-induction when Sfp1p is knocked-out; however, there is some 
uncertainty as to whether this is Hmo1p-related. Chromatin Immunoprecipitation 
techniques were then used to demonstrate that RNA polymerase II is evicted from the 
HMO1 gene over the course of one hour during stress when Tor1p is knocked-out. This 
same phenomenon had previously been shown in wild-type cells; however, HMO1 
transcripts are only attenuated in wild-type cells, and not when Tor1p is knocked-out. This 
suggests that mTORC1 is responsible for the reduction of HMO1 mRNA during stress. 
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We propose the possibility that mTORC1 is participating in active mRNA degradation at 





CHAPTER 1. INTRODUCTION AND BACKGROUND 
1.1. Chromatin 
The genetic material of eukaryotic organisms is comprised of DNA compacted into 
higher-order structures by means of nucleoprotein complexes, thus forming chromatin 
(1,2,3). These complexes, the nucleosomes, consist of approximately 146 DNA base 
pairs wrapped 1.7 times around 2 copies each of H2A, H2B, H3, and H4, altogether 
forming a histone octamer (1,2). Each H2A and H2B histone are dimerized, forming two 
H2A/H2B heterodimers, while the H3 and H4 histones collectively form a (H3/H4)2 
heterotetramer (2). The negatively-charged phosphodiester backbone of the DNA is 
attracted to the positively charged amino acid residues (notably those of lysine and 
arginine) that are common in histone core particles, creating a first-order compaction of 
chromatin known as the 11-nanometer (nm) “beads on a string” (26). In this conformation, 
the N-terminal tails of each histone jut out from the nucleosome and contact neighboring 
chromatin proteins as a means of regulating higher-order structures (21). 
Linker DNA connects adjacent nucleosomes and may be bound by linker histones. 
Metazoan cells contain the linker histone H1, which is localized to where linker DNA 
enters/exits the nucleosome (1). H1 allows the “beads on a string” to further compact by 
means of its lysine-rich C-terminus as well as its globular “winged-helix-turn-helix” domain 
(1). This causes the DNA to coil into a 30-nm fiber (secondary structure), which can further 
compact into still higher order (tertiary) structures depending on the stage of the cell cycle. 
Chromatin itself can be classified as being in one of two states: heterochromatin or 
euchromatin. Heterochromatin is heavily supercoiled and highly condensed, preventing 




inactive (21). Its dense nature allows it to resist nuclease activity, providing some means 
of protection (25). On the other hand, euchromatin is accessible to gene expression 
proteins due to its relatively loose coiling and unpacked nature. Therefore, euchromatin 
is generally transcriptionally-active (21). 
Histones can be modified through the attachment of several different possible 
functional groups, which can affect the heterochromatin-euchromatin dynamics. Among 
the more commonly detected modifications are the acetylation of lysine residues’ ϵ-amino 
groups. The negative charge of the DNA phosphodiester backbone makes it highly 
attracted to positively charged side chains, such as lysine; therefore, the neutralization of 
these side chains would attenuate the interactions between the two. The addition of acetyl 
groups via histone acetyltransferases (HATs) does exactly that, and this is generally 
accompanied by an increase in gene transcription. This process is reversed via histone 
deacetylases (HDACs), and the coordination of these two enzymes helps regulate the 
transcriptional output of affected genes. In addition, the acetylated lysines of histones 
serve as binding sites for certain binding-domains, such as PHD fingers and 
bromodomains. For example, the SWI/SNF remodeling complex, which opens the DNA 
around the nucleosome core, uses the bromodomain of Swi2/Snf2 to recognize 
acetylated lysines (9).  
In addition to acetylation, methylation of histones has been shown to affect 
transcription regulation, albeit by a different mechanism. Rather than altering chromatin 
dynamics, the addition of methyl groups to lysine and arginine residues has been shown 
to recruit specific proteins that perform specific functions (9). Histone methylation has also 




interference (10). Another type of histone modification, phosphorylation, has been shown 
to be important in various DNA-related processes, including the regulation of gene 
expression, particularly of proliferative genes. There is also a significant connection 
between histone phosphorylation and chromatin compaction associated with mitosis and 
meiosis (11).  
Of particular note, however, is the role of histone phosphorylation in DNA repair 
processes. DNA double-strand breaks (DSBs) are cuts in the phosphodiester backbones 
of both DNA strands at a complementary location, which thereby sheer a single double-
strand DNA molecule into two. In mammalian cells, if left unaided for too long, these DSBs 
can prove detrimental to cellular health by promoting cancer and other diseases. 
Therefore, when DSBs occur, the cell responds by generating a sequence of events, 
known as the DNA-damage response, in order to repair the damage. In order for DNA 
repair to occur, however, chromatin remodeling must take place to allow repair proteins 
to access the damage site. Histone phosphorylation is one of the earliest steps in this 
process, taking place on H2A at serine-129 in yeast and on H2AX (an H2A variant) at 
serine-139 in mammals, thereby generating -H2AX. This phosphorylation is the initial 
step in activating homologous recombination, non-homologous end joining, and other 
DNA-damage responses (2,3,8,11,12). 
1.2. Saccharomyces cerevisiae  
The budding yeast Saccharomyces cerevisiae, commonly known as baker’s yeast 
(hereafter simply referred to as “yeast”), is a unicellular fungus [1] that is regularly used 
as a laboratory model organism, due to its relatively fast life cycle and the evolutionary 




consists of both haploid and diploid stages, depending on environmental factors. In the 
haploid stage, its DNA is compacted into 16 nuclear chromosomes (22) that altogether 
form a genome approximately 24 Mbp in length (23). In this stage, yeast reproduces 
through budding of a new daughter cell from the parent cell, ultimately leading to nuclear 
mitosis and the separation of the bud to form a new diploid cell. During environmental 
stress, diploid cells begin the process of sporulation by means of meiosis. The cell then 
becomes an ascus, forming four spores within itself before its wall breaks down (24).  
The spores are the yeast haploid cells, each one containing a copy of the Mating-
Type Locus (MAT). Cell mating-types are distinguished through two non-homologous 
alleles, designated as “a” and “α”. Depending on its mating-type, each haploid cell 
produces one of two types of pheromones: the 13 amino acid a-factor or the 12 amino 
acid α-factor. Special receptors recognize the pheromone of the cell’s opposite mating-
type, and the cell cycle is arrested at G1. Proteins essential for the mating process are 
synthesized in each cell, and an extension of each cell’s plasma membrane (and cell wall) 
grow toward the targeted mate (24). These “shmoos” meet at their projections, where 
they fuse their cytoplasms to form a single cell (27). Afterward, karyogamy, or nuclear 
fusion, occurs, generating a diploid zygote (MATa/α) and completing the life cycle (24). 
In addition to MAT, yeast cells contain the transcriptionally-silent loci denoted as 
HMRa and HMLα that contain the genetic information for expression of the “a” and “α” 
phenotypes, respectively. Silent information regulator (SIR) genes prevent these loci from 
being expressed. However, their information can be copied to MAT via duplicative 
transposition in order to switch the mating-type of the cell. This process is initiated by the 




targets an 18 bp sequence in the MAT locus and generates a DSB (24) with sticky ends 
(28). DSB repair mechanisms delete the mating-type cassette in MAT, after which it is 
repaired through the replication of the opposite mating-type cassette within its locus (24). 
This mechanism can be exploited for experimental purposes to test the effects of DSBs 
in yeast (Figure 1).  
 
Figure 1. Mechanism of Controlled Induction of DSBs. A plasmid encoding HO under 
control of the GAL1 promoter is transformed into yeast and galactose is supplied as a 
carbon source in order to activate the promoter and induce transcription of HO 
endonuclease. The endonuclease then targets the MAT locus and creates a DSB. As the 
target site of HO endonuclease is specific, this provides a means of experimental control, 
preventing the DSB from occurring at random sites, which would potentially damage 
essential genes. 
 
Yeast also contains a special linker histone called Hho1p, which is distinguished 
from metazoan H1 by its possession of two globular domains. One of these domains is 
very similar to that of H1, suggesting homology between the two proteins. In yeast, this 
domain, which adopts a similar fold to that of H1, has been shown to protect against 
nuclease activity by means of nucleosome-binding (2,8). Hho1p’s second globular 




presence of concentrated tetrahedral anions, binds most efficiently to DNA four-way 
junctions (2). During stationary phase, Hho1p assists in genomic compaction by forming 
loops along the length of the nuclear DNA, further linking it to metazoan H1 functions. 
Unlike H1, however, Hho1p does not contain a basic C-terminus; rather, its lysine-rich 
domain is enclosed between its two globular domains, preventing it from participating in 
chromatin reorganization (2,8). In addition, the stoichiometry of Hho1p to nucleosomes in 
yeast is significantly lower than that of its metazoan counterpart (2). 
1.3. The High-Mobility Group Box Protein Hmo1p 
High-mobility group box (HMGB) proteins are eukaryotic nuclear proteins that are 
highly involved in DNA-dependent processes. They are typically defined by their “HMG-
Box” domains (2,3,8), which consist of three α-helices that are arranged in an L-shaped 
motif that plays significant roles in DNA interactions (2). There are two categories of 
HMGB proteins: sequence-specific and non-sequence-specific. By definition, sequence-
specific HMGB proteins are specialized transcription factors, only being expressed in 
specific cell types. In contrast, non-sequence-specific HMGB proteins are common to all 
eukaryotic cells and play a major role in chromatin dynamics. They are considered 
“architectural” by definition, as their HMG-Box domains act to bind/bend DNA targets. As 
a consequence of this, they tend to display a high affinity to pre-bent DNA. DNA-bending 
via HMGB proteins is accomplished through the energy derived from the electrostatic and 
van der Waals interactions made between the HMG-Box domain and the DNA minor 
groove. As the minor groove widens due to the insertion of the HMG-Box, the major 




Non-sequence-specific HMGB proteins usually contain two HMG-Box domains 
(Box A and Box B) that have higher affinity for non-B-form DNA, including four-way 
junctions, somewhat linking their functionality to Hho1p. In mammals, HMGB proteins 1-
4 contain acidic C-termini, which interact with Box A and Box B to block them from being 
able to bind to DNA. In the case of nucleosomes, however, it is believed that the N-
terminus of histone H3, which contacts linker DNA by passing through the DNA entry-exit 
point, interacts with the acidic C-terminus to allow the binding of the box domains to the 
entry-exit point, distorting the nearby DNA. In turn, this creates a chain reaction of DNA-
unwinding around the nucleosome core, generating a loosely-packed chromatin 
environment associated with transcriptional activation. As a result, mammalian HMGB 
proteins engage in competitive nucleosome-binding against the linker histone H1, leading 
to dynamic chromatin-regulation methods (2,8). 
Of the many HMGB proteins found in yeast, Hmo1p and Hmo2p are notable as 
having two separate globular domains that heavily resemble HMG-Boxes (hereafter 
referred to as Box A and Box B) (2). Hmo1p, in particular, has been found to not only 
possess HMGB characteristics, but also those of linker histones, due in part to its lysine-
rich C-terminus. Along with its terminal domain, Hmo1p’s Box A and Box B domains 
further contribute to chromatin compaction (2,3,8,14). Box A domains dimerize in order 
to bend Hmo1p-bound DNA (2,14), and although it has low affinity for B-form DNA, it 
possesses structural specificity for other forms, particularly four-way junctions (similar to 
HMGB proteins and Hho1p) (2). Box B, on the other hand, is mostly responsible for the 





Two models of Hmo1p-mediated DNA stabilization have been proposed. The first, 
as mentioned above, involves the dimerization of Hmo1p’s Box A domains, which 
happens particularly in nucleosome-free DNA. The second, which occurs at the 
nucleosome dyad when it is bound by Box A, involves the lysine-rich C-terminus 
preventing DNA unwinding around the nucleosome through its association with the linker 
DNA. This particular characteristic contrasts Hmo1p with typical mammalian HMGB 
proteins, which typically bind to nucleosome dyads to loosen the DNA (2). Hmo1p has 
been shown to localize to the MAT locus, and of particular interest is its tendency to 
become evicted following 2 hours of continuous DSBs (3,5,8). This provides a simple 
means of control while performing experiments relating to DSBs. In addition to DNA 
compaction, Hmo1p has been shown to be involved in transcriptional activity, particularly 
at the promoters of ribosomal biogenesis (Ribi) genes, various ribosomal protein (RP) 
genes, and even the HMO1 gene itself (2,3,8,5,14).  
Due to its ability to stabilize chromatin, Hmo1p has a significant effect on DNA 
repair efficiency. It has been demonstrated that in the absence of Hmo1p, cell survival is 
significantly increased during continuous DSBs. It is believed that when chromatin is 
heavily compacted by Hmo1p, DNA repair proteins have a more difficult time accessing 
the DSB sites. Thus, a less-condensed chromatin environment would allow for a greater 
chance of DNA-damage repair and, therefore, continued cell survival (2,3,8) 
1.4. The Target of Rapamycin Complex 1 (TORC1) 
In order for cells to carry out a response to a particular stimulus, specialized 
proteins must relay the signal within the cell. Protein kinases accomplish this by 




other cellular proteins. The yeast serine-threonine kinase TORC1 (target of rapamycin 
complex 1), a multi-protein complex containing the catalytic Tor1p (5,20) is a significant 
regulator of cellular development, playing roles in the expression of ribosome-related 
genes (2,5,14,16,17,18,20) as well as various RNA polymerase II (Pol ll)-transcribed 
genes (5,17,18). rRNA genes are regulated by TORC1 through direct contact (2,5), while 
RP and Ribi genes are regulated indirectly via downstream phosphorylation targets, such 
as the AGC family protein kinase Sch9p (2,5,9) and the zinc-finger transcription factor 
split finger protein 1 (Sfp1p). Sfp1p itself has been shown to be required for maximal 
ribosome production in yeast, which makes sense in context with its tendency to bind to 
RP promoters (2,5,17,18,19). Furthermore, Sfp1p’s overall localization within the cell 
appears to be dependent on TORC1: while TORC1 is inactive, Sfp1p remains in the 
cytoplasm, hindering it from participating in gene regulation. Its localization to the nucleus 
is reserved for instances of TORC1 activation (2,5,18,19). 
Several different proteins make up the overall complex of TORC1. In yeast, these 
subunits are called Tor1p (or possibly Tor2p), Kog1p, Tco89p, and Lst8p (5,13,20). In 
mammalian cells, the complex, originally referred to as mammalian TORC1, contains a 
specific mammalian TOR (mTOR) protein along with the regulatory-associated protein of 
mTOR (RAPTOR), mLst8, the proline-rich Akt substrate of 40 kDa (PRAS40), and the 
disheveled, Egl-10, and Pleckstrin domain-containing mTOR-interacting protein 
(DEPTOR). RAPTOR is the ortholog of Kog1p, while PRAS40 and DEPTOR take the 
place of Tco89p (13,20). The catalytic subunits, Tor1p/Tor2p and mTOR, are 
phosphatidylinositol kinase-related kinases (PIKKs). In yeast, both Tor1p and Tor2p can 




TORC1 has been heavily conserved throughout evolution from yeast to mammals, 
making it a commonality among eukaryotes under the collective name “mechanistic 
TORC1” (hereby referred to as “mTORC1”) (5,13,20). As its name implies, mTORC1 is 
inhibited by the Streptomyces hygroscopicus-produced macrolide rapamycin, which 
binds to the 12-kDa FK506-binding protein (FKBP12). This complex gains the ability to 
block the Tor1p/Tor2p active site by binding to its FKBP-rapamycin-binding (FRB) 
domain, thus inhibiting catalytic potential (13,20). It has further been demonstrated that 
cellular stress (DSBs in particular) mimics this inhibition response (5). In regards to 
HMO1, mTORC1 is responsible for relaying the stress signal to the promoter, as a 
decrease in HMO1 transcript levels is only observed after induction of DSBs when Tor1p 
is present (5). This was surprising, considering how Tor2p has been shown to take the 
place of Tor1p as the catalytic subunit when necessary. This suggested that Tor1p had a 
more specific function in regulating the HMO1 promoter; in particular, Tor1p may be 
localizing to the promoter and performing some direct activity. Chromatin 
immunoprecipitation (ChIP) techniques have confirmed that it binds directly to the HMO1 
promoter (5), and while a similar behavior has been demonstrated at other genes 
(including the aforementioned rRNA genes), its role in binding to this particular promoter 
is currently unknown.   
Pol ll eviction throughout the HMO1 gene has been shown to occur within 1 hour 
of DSB induction in wild-type (WT) yeast cells (5), providing what was once a possible 
explanation for the accompanied decrease in transcript levels. However, preliminary data 
has suggested a similar phenomenon in tor cells (Ashish Gupta, unpublished data), 




observation that HMO1 transcript levels do not decrease in response to DNA damage 
when Tor1p is absent, even though Pol ll leaves the gene, indicates that mTORC1 is 
somehow responsible for the response. As such, this may be a key piece of evidence for 
explaining why mTORC1 binds to particular genes. 
The relationship between Hmo1p and mTORC1 has been of particular interest in 
our lab; therefore, my aim was to further study this relationship in regards to DNA damage. 
With evidence suggesting that Sfp1p may also be involved in this interaction, I first looked 
into the possibility of Sfp1p’s involvement in HMO1 regulation via mTORC1 signaling by 
conducting both survival and gene expression analysis experiments. I then sought to 
determine the precise role of mTORC1-binding at the HMO1 gene by demonstrating Pol 













CHAPTER 2. MATERIALS AND METHODS 
2.1. Gene Expression Analysis 
Cultures of two Saccharomyces cerevisiae strains, DDY3 (our experimental WT) 
and DDY3-sfp1, were grown in synthetic minimal uracil-dropout (-URA) media and 
tryptophan-dropout (-TRP) media, respectively, at 30C with constant shaking to 
exponential phase (OD600~0.4-0.8). Both strains had previously been transformed with 
a plasmid encoding HO endonuclease under control of the GAL1 promoter and marker 
genes for uracil (DDY3) and tryptophan (DDY3-sfp1) (See 5). Both were supplemented 
with raffinose as a carbon source (2% final concentration). 15 mL of culture were pelleted 
and washed with diethyl pyrocarbonate (DEPC)-treated water (0-hour control). The 
remaining culture was then treated with galactose (2% final concentration) and incubated 
at room temperature for 1 hour with constant shaking, after which 15 mL were pelleted 
and washed with DEPC-treated water. Pellets were stored at -80C overnight. 
Pellets were thawed and total RNA was extracted via illustra RNAspin Mini RNA 
Isolation Kit (GE Healthcare), after which TURBO DNase (Ambion) was used to degrade 
contaminating genomic DNA. PCR was used to confirm complete removal of DNA. 
NanoDrop (Thermo Scientific) was used to determine total RNA concentrations and 
dilutions were made. 1 µL of 20 mM reverse primer (5’-
TCTCCAACTCGACGTTGTAAGCCTGC-3’) was added to ~100 ng of total RNA in a 
separate 1.5 mL Eppendorf tube and sterile ddH2O was added to make the total volume 
13 µL. Samples were incubated at 65C for 5 minutes and then placed on ice for 5 minutes 
to allow primer annealing and fixation. AMV Reverse Transcriptase (New England 




dNTPs, 2 µL 10x AMV Reverse Transcriptase Reaction Buffer, and 1 µL AMV Reverse 
Transcriptase (10,000 units/mL) were added to make a 20 µL reaction volume. The entire 
mixture was placed in a 42C water bath for 1 hour, and resulting samples were stored at 
-20C. cDNA was verified using PCR. 
For quantitative-PCR (qPCR), samples were prepared in triplicate, 20 µL reactions 
in a 96-well plate using Luna Universal qPCR Master Mix (New England Biolabs). Primer 
sequences used for the open reading frame (ORF) were 5’-
AAGATAGAGGCTTTCACCACTTTGAC-3’ (forward) and the aforementioned cDNA-
generating primer (reverse). A QuantStudio 6 Flex Real-Time PCR System (Applied 
Biosystems) was used to carry out qPCR. The IPP1 gene was used as a reference 
(primers: 5’-CCCAATCATCCAAGACACCAAGAAGG-3’ [forward], 5’-
AGCAATAGTTTCACCAATTTCCAACACATC-3’ [reverse]). Relative expression levels 
were calculated via the Ct method.  
2.2. Survival Tests 
The aforementioned strains were both grown to exponential phase (OD600~0.5-
0.8) and treated with galactose as described above. 1 mL of culture was collected prior 
to treatment and every hour thereafter for up to 4 hours and diluted to 1000x, after which 
50 µL were plated on either synthetic minimal -URA or -TRP agar media with raffinose 
(2% final concentration) and incubated at 30C for 2-5 days. Colonies were counted and 
used to determine the concentration of the treated, undiluted sample through the following 
equation: (# of Colonies * 1000µL * 1000x) / (50µL * OD600) 




ChIP was performed using the same protocol as described in (5) with the following 
alterations. Cultures of DDY3-tor1 containing the aforementioned HO/uracil marker 
plasmid were grown in synthetic minimal -URA media with raffinose (2% final 
concentration) in 30C with constant shaking to exponential phase (OD600~0.5-0.8). A 50 
mL sample of culture (0-hour control) was collected and treated with formaldehyde (3% 
final concentration) and left to shake at room temperature for 20 minutes to allow DNA-
protein crosslinking, after which the sample was pelleted and washed with 1x phosphate-
buffered saline (PBS). The remaining culture was treated with galactose (2% final 
concentration) to induce DSBs and incubated at room temperature for 1 hour with 
constant shaking. 50 mL samples were collected at 15, 30, and 60 minutes, treated with 
formaldehyde as described above, pelleted, and washed with 1x PBS. Pellets were stored 
at -80C overnight.  
ChIP lysis buffer (50 mM HEPES [pH 7.5], 140 mM NaCl, 1% Triton X-100, 0.1% 
sodium deoxycholate) with protease inhibitor was prepared using one tablet of Roche 
cOmplete protease inhibitor cocktail (mini, EDTA-free) dissolved in 1.5 mL sterile ddH2O, 
which was then added at 10 µL/mL lysis buffer (mixture hereby referred to as PI). 400 µL 
PI was added to each thawed pellet along with 500 µL of acid-washed glass beads (~500 
µm) and left to vortex in 1.5 mL Eppendorf tubes at 4C for 40 minutes. 10 µL 100 mM 
phenylmethylsulfonyl fluoride (PMSF) dissolved in isopropanol was added to each 
sample, and flame-heated 26G syringe needles were used to poke through the bottoms 
of the tubes, after which each pierced tube was placed within a second tube and briefly 
centrifuged to allow the total cell extract to filter through. Samples were sonicated for 10 




1 minute between sonications. Remaining cell debris was removed through 
centrifugation, and 10 µL PMSF was added. 20 µL of the resulting whole-cell extract 
(WCE) was used to check for chromatin fragment size, while the rest was stored in -80C. 
The 20 µL WCE was added to 200 µL of immunoprecipitation elution buffer (IPEB) 
(100 µL 1 M NaHCO3, 50 µL 20% SDS, 850 µL sterile ddH2O) and 10 µL 5M NaCl, and 
the total mixture was incubated at 65C for 4 hours to reverse crosslinking. 
Phenol/chloroform was used to extract DNA, and RNase A (final volume 60 µg/mL) was 
used to remove total RNA in 25 µL 1x TE at 37C for 30 minutes. Samples were run on 
1% agarose gels to determine fragment sizes (target size: 300-1000 bp). 
Protein G-Sepharose 4 Fast Flow (GE Healthcare) beads were prepared by taking 
35 µL of beads per sample (including antibody immunoprecipitation [AIP] and no antibody 
control [NA]) and washing them with PI (105 µL per sample) 3 times via centrifugation 
(8000 RPM, 3 minutes). Bead resuspension buffer (2.4 mL PI, 88 µL salmon sperm DNA 
[200 µg/mL], and 120 µL bovine serum albumin [500 µg/mL]) was used to dilute beads 
back up to their original volume (35 µL per sample). For each sample, 100 µL WCE was 
mixed with 300 µL PI and 30 µL beads and left to rock on a nutator for 1 hour at 4 C for 
preclearing. Beads were then removed via centrifugation and 2 µL anti-RNA polymerase 
II CTD was added to each AIP sample. AIP and NA samples were then left to rock on a 
nutator at 4C for 10 hours, and after the addition of 30 µL prepared beads, samples were 
left to rock for another 12 hours. 
Beads were separated from solution via centrifugation and washed for 15 minutes 
using lysis buffer via rocking on nutator at 4C. Centrifugation was used to separate 




sterilized), IP wash buffer 2 (10 mM Tris [pH 8], 250 mM LiCl, 0.5% NP-40, 0.5% sodium 
deoxycholate, 1 mM EDTA, filter sterilized), and 1x TE (twice). After removing second TE, 
each sample was treated with 250 µL IPEB and shaken at 150 RPM at room temperature 
to elute crosslinked protein-DNA from beads. Samples were centrifuged and 225 µL of 
the resulting supernatant of crosslinked protein-DNA was transferred to a separate 
sterilized Eppendorf tube. The process was repeated with the left-over beads and the 
supernatant added to the first collection. 100 µL of remaining WCE per sample was 
thawed and mixed with 475 µL IPEB and 20 µL 5 M NaCl, acting as the input control (IC). 
Each bead-eluted sample was also treated with 20 µL 5 M NaCl, and all samples were 
subjected to 65C incubation for 4 hours to undo formaldehyde crosslinking. All samples 
were then treated with 20 µL 1 M Tris (pH 8), 10 µL 0.5 EDTA, and 1 µL Proteinase K 
and left to incubate at 55C for 30 minutes. Phenol/chloroform extraction was used to 
remove remaining protein, and DNA was collected using ethanol precipitation. DNA was 
resuspended in 200 µL 1x TE and treated with RNase A (final volume 60 µg/mL) at 37C 
for 30 minutes. PCR was performed using 17.8 µL sterile ddH2O, 1 µL Taq DNA 
Polymerase with 3 µL Standard Taq Buffer (New England Biolabs), 1 µL each of the 
aforementioned ORF 20 mM forward and reverse primers, 0.6 µL 25 mM dNTPs, and 3 
µL 25 mM magnesium chloride (27.4 µL reaction). Samples were run on a 1% agarose 
gel, and ImageJ imaging software was used to quantify band intensities. IC and NA bands 







CHAPTER 3. RESULTS AND DISCUSSION 
3.1. Sfp1p is Involved in Regulating the HMO1 Promoter 
Based on the idea that DNA damage inhibits mTORC1 signaling, our lab has 
previously shown that DNA damage reduces HMO1 transcript levels, but only when Tor1p 
is present, indicating that mTORC1 is involved in transmitting the stress signal to the 
promoter (5). As mentioned above, we had reason to believe that Sfp1p may be involved 
in HMO1 promoter regulation, and that inducing DSBs may have a different effect on 
transcript levels depending on whether Sfp1p was present or not. We used WT and sfp1 
strains containing plasmids encoding the HO endonuclease under control of the GAL1 
promoter to induce DSBs by adding galactose as a carbon source. Total RNA was 
extracted from cells and subjected to qPCR to measure Ct values. to Using the Ct 
method, it was determined that Sfp1p does not have a significant effect on HMO1 
expression in the absence of DSBs, indicating that Sfp1p is not involved in normal HMO1 
expression during exponential growth (Figure 2A). However, after inducing DSBs, it was 
clear that Sfp1p is somehow involved in relaying the stress signal to the promoter, as 
expression levels fail to go down in a sfp1 strain (Figures 2B and 2C). Thus, there is a 
similar response to DSBs between tor1 and sfp1 cells, indicating that the two proteins 
may be interacting at the promoter. This makes sense in context with Sfp1p’s role as a 
downstream phosphorylation target for mTORC1 at RP gene promoters, and this further 
emphasizes a similarity in gene regulation between RP genes and other Pol ll-transcribed 




                    
 
Figure 2. Sfp1p’s Effects on HMO1 Transcription. (A) Bar graph representing relative 
HMO1 transcript levels between WT and sfp1 during exponential growth. (B) Bar graph 
representing relative WT HMO1 transcript levels between untreated samples (WT 0) and 
samples that have undergone 1 hour of DSB induction via galactose-mediated expression 
of HO endonuclease (WT 1). (C) Bar graph representing relative sfp1 HMO1 transcript 
levels between untreated samples (sfp1 0) and samples that have undergone 1 hour of 
DSB induction via galactose (sfp1 1). IPP1 was used as a reference gene. Expression 
values normalized to untreated (0 Hr) cells. Means and standard deviations are 
representative of 3 replicates.  
 
It is worth noting that cells were pelleted at a wide range of concentrations. 























































of the exponential growth phase, as was the reasoning during this experiment. While this 
appears to hold true in WT, the sfp1 fold changes have exceptionally wide error bars 
around their means, indicating the likelihood of more concentration-sensitive transcription 
regulation. What we can conclude from this data is that Sfp1p is having some sort of effect 
on HMO1 transcription during DSBs, likely acting as a signaling mediator between 
mTORC1 and the promoter.  
Based on the idea that Hmo1p stabilizes chromatin and its absence results in more 
efficient DNA repair, we wanted to test the possibility that Sfp1p made a difference in cell 
survival during consistent DSBs. Based on the aforementioned gene expression data, it 
could be predicted that in a sfp1 strain, cell survival would be similar to that of WT, as 
the mTORC1 stress signal would fail to reach the HMO1 promoter, thus permitting 
standard cellular levels of Hmo1p. Considering how Hmo1p remains at the MAT locus for 
2 hours of DSBs, we first wanted to test if the absence of Sfp1p changed this behavior. 
WT and sfp1 cultures containing the GAL1-HO plasmid were grown to exponential 
phase and treated with galactose to induce expression of the HO endonuclease in order 
to generate DSBs, after which cells were diluted, plated, and incubated at 30C for several 
days. WT and sfp1 cells that were subjected to 2 hours of DSBs before being plated 
showed no significant difference in survival (Data not shown), prompting us to extend 
DSB treatment to 4 hours. Conducting 4-hour survival tests in WT revealed expected 
results, as judging simply by the generated error bars, cell survival clearly decreases after 
4 hours of consistent DSBs (Figure 3). The results of sfp1 survival, on the other hand, 
generated more complicated results. While the average number of colony-forming units 




deviations between untreated and DSB-induced cells (Figure 3). Based on this 
observation alone, we could conclude that the absence of Sfp1p slightly enhances the 
DNA repair process, which contradicts the logic of our hypothesis. Considering the 
previous data that suggests that Sfp1p is not required for standard HMO1 transcription, 
cellular levels of Hmo1p should remain the same in sfp1 as in WT. Taken altogether, 
the data suggests that Sfp1p may possibly be hindering DNA repair through other 
biochemical pathways; in particular, its role in ribosome biogenesis may be producing 
some effect that makes DSB repair more difficult. 
 
Figure 3. Sfp1p’s Effects on DSB Survival. Bar graph representing the quantification of 
calculated CFU/mL of culture between WT and sfp1 cells before galactose treatment (0 
Hr) and after 4 hours of DSB induction via galactose (4 Hr). Means and standard 
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3.2. mTORC1 is Likely Inducing mRNA Degradation During Stress 
 As mentioned above, mTORC1 inhibition, whether through rapamycin-treatment 
or stress, leads to a reduction in HMO1 transcript levels. Our lab has previously 
demonstrated an eviction of Pol ll throughout the HMO1 gene shortly after inducing 
mTORC1 inhibition, initially providing a possible explanation for the transcript decrease. 
However, preliminary data later suggested that the same Pol ll eviction occurs in tor1 
cells, where HMO1 transcripts remain high, suggesting that the decrease in transcript 
levels is not simply the result of the removal of Pol ll (Figure 4A). In order to verify this 
finding, multiple replicates of ChIP were performed using an anti-Pol ll antibody to 
measure occupancy along the HMO1 ORF in a tor1 strain. As expected, Pol ll-binding 
was attenuated over time, with high significance (p<0.05) at the 60-minute mark (Figure 
4B and 4C). 
 These observations highly suggest that the relative amounts of HMO1 transcripts 
during DSBs is dependent on the presence or absence of mTORC1 rather than Pol ll. 
One possible explanation is that mTORC1 is actively participating in transcript 
degradation. This is likely the case, as previous studies have demonstrated a similar 
function at other genes: Talarek, et al. demonstrated that mTORC1 uses the Rim15-
Igo1/2-PP2ACdc55 effector branch to manage the stability of transcripts that come from 
genes that use Msn2p/Msn4p and Gis1p as transcription factors (6), while Albig and 
Decker had shown that mTORC1-mediated degradation of certain mRNAs through 
deadenylation/reduced adenylation and decapping (7). Interestingly, mTORC1 has also 
been found to be a negative regulator of exosome release in mouse embryo fibroblasts, 




mRNA degradation by mTORC1 may be justified by two possible theories. First, the cell 
may prefer to allocate the energy used during the gene translation process to that of DNA 
repair. Second, the cell realizes that high levels of Hmo1p would hinder the DNA repair 
process, and so it degrades its own HMO1 transcripts to prevent an accumulation of 
Hmo1p within the cell (2,3,8; Figure 3).  
         
   
Figure 4. Pol ll is Evicted from HMO1 During DSBs. (A) Simplified visual model of the 
effects of DSBs on HMO1 transcription in the presence (top) and absence (bottom) of 
mTORC1 signaling. (B) Gel images representing one replicate of ChIP performed at 
the HMO1 promoter in tor1 using the Pol ll antibody (IC = Input Control; NA = No 
Antibody Sample; IP = Antibody-Immunoprecipitated Sample). (C) Graphical data 
representing the relative ImageJ-quantified band intensities of standardized IP bands 
over the course of 60 minutes (Min). Means and standard deviations are 
representative of 3 (0, 15, and 30 Min) and 2 (60 Min) replicates. p < 0.05 determined 






CHAPTER 4. CONCLUSION AND FUTURE DIRECTIONS 
Hmo1p is an important component of both gene transcription and chromatin 
stability, and our experiments here further emphasize this. First, we show how the 
transcription factor Sfp1p is somehow involved in the biochemical pathway leading to 
HMO1 regulation. More specifically, it is likely a factor in relaying the mTORC1 stress 
signal to the promoter. As our wide range of OD600 readings seems to have been the 
cause of the wide error bars around the sfp1 means (Figures 2A and 2C), redoing the 
experiment with narrower cell concentration limits is advised in order to determine Sfp1p’s 
precise role in HMO1 regulation. In addition, its presence may be a hinderance to DSB 
repair, although the means by which it is are unclear. Considering its role in binding to RP 
promoters as a means of activation, it is possible that Sfp1p could be doing the same 
thing at the HMO1 promoter; therefore, we propose generating a FLAG-tagged Sfp1p 
strain in order to determine this phenomenon via ChIP. Furthermore, Western Blotting 
can be used to test the previously-stated hypothesis that there should be no difference in 
cellular Hmo1p concentrations between WT and sfp1 strains. In addition, predicted 
binding sites within the HMO1 promoter (5) suggest the possibility of Reb1p being 
involved in transcription regulation. In particular, Reb1p is evicted from the HMO1 gene 
during an overaccumulations of Hmo1p (5), which generates a negative-feedback 
response on its own promoter (5,14), pointing to the possibility of Reb1p being a 
transcriptional activator.  
 Second, we demonstrated that Pol ll is evicted from the HMO1 gene during stress 
regardless of whether Tor1p is present. Since we used only ORF-spanning primers, it is 




region in order to validate that Pol ll is either being evicted at the transcription preinitiation 
complex or failing to reach the promoter altogether. Considering that HMO1 transcript 
levels are significantly reduced during DSB only when Tor1p is present, we propose that 
mTORC1 may be playing a role in HMO1 transcript degradation during stress. In order to 
test this hypothesis, we suggest using actinomycin D to halt the transcription process in 
both WT and tor1 cells. Actinomycin D is a commonly used transcriptional inhibitor that 
stabilizes the covalent bonds formed between topoisomerase I and DNA by intercalating 
into GC-rich sequences. As a result, Pol ll will be stopped during the mRNA synthesis 
process, ultimately leading to transcriptional failure (15). After collecting a 0-hour control 
and adding actinomycin D, transcripts can be extracted and quantified in order to 
determine the difference in mRNA half-lives between the two strains. Previous studies 
have established how mTORC1’s roles may go beyond signal transduction, and that all 
of these activities interplay to keep cellular metabolism in check. These findings may 
therefore have some medical significance, as faulty mTORC1 activity in mammals have 
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